Catelani Michael 4
4 · Anixa Biosciences Inc · Filed Apr 15, 2022
Insider Transaction Report
Form 4
Catelani Michael
President, COO & CFO
Transactions
- Award
Employee Stock Option (Right to Buy)
2022-04-14+100,000→ 100,000 totalExercise: $2.62Exp: 2032-04-14→ Common Stock (100,000 underlying)
Footnotes (2)
- [F1]Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan.
- [F2]The options vest and become exercisable in thirty-six (36) equal monthly installments beginning April 30, 2022.